Two Washington University doctors have been leading a national effort to study convalescent plasma, a centuries-old treatment for infectious diseases, and believe they have submitted enough data to secure federal approval for emergency use against COVID-19. Doctors have been injecting coronavirus patients with plasma since March. But approval by the U.S. Food and Drug Administration could vastly expand use of the treatment, which has shown some success, here and across the country.
